Montana 2025 Regular Session

Montana Senate Bill SB503

Introduced
2/25/25  
Refer
2/26/25  
Engrossed
3/7/25  
Refer
3/17/25  
Enrolled
4/11/25  

Caption

Allow use of expired opioid antagonists

Impact

The passage of SB503 would amend existing Montana statutes to ensure that schools can maintain a stock supply of opioid antagonists, such as naloxone, and effectively train staff for their administration. This means more individuals and institutions would be able to respond swiftly to opioid overdoses, potentially saving lives where immediate medical assistance might not be available. Additionally, it ensures that those administering these medications would not face legal action unless they acted with gross negligence.

Summary

Senate Bill 503 (SB503) aims to expand the accessibility and use of opioid antagonists, specifically allowing the use of expired opioid antagonists without the fear of legal repercussions. The bill provides partial immunity from civil or criminal liability for medical practitioners, pharmacists, school employees, and eligible recipients who administer or distribute these medications during opioid overdose emergencies. The intent is to save lives by promoting broader use and distribution of these lifesaving drugs.

Sentiment

General sentiment towards SB503 appears to be supportive, with legislators and advocacy groups recognizing the importance of increasing access to opioid antagonists in the face of the ongoing opioid crisis. Proponents argue that the bill provides essential legal protections that encourage more people to carry and use these medications. However, there may be concerns regarding the implications of allowing the use of expired medications, questioning their effectiveness and safety in overdose situations.

Contention

One potential point of contention lies in the provision that allows for expired opioid antagonists to be used, as this raises questions about efficacy and public safety. Some opposition may arise from those worried that this allowance could promote negligence in medication practices. Additionally, while the immunity provisions are intended to foster a supportive environment for life-saving interventions, there may be concerns about the ethical implications of using expired substances, leading to debates about how best to balance these interests.

Companion Bills

No companion bills found.

Similar Bills

HI HB310

Relating To Opioid Antagonists.

CA AB2256

Law enforcement agencies: opioid antagonist.

CA AB24

Emergency response: opioid antagonist kits.

CA SB234

Opioid antagonists: stadiums, concert venues, and amusement parks.

MI HB5077

Health: pharmaceuticals; distribution of naloxone under the administration of opioid antagonist act to any individual; provide for. Amends title & secs. 103 & 107 of 2019 PA 39 (MCL 15.673 & 15.677) & adds sec. 106.

MS SB2336

Prevention of overdoses; authorize administration of opioid antagonists by certain persons, provide immunity to.

MS SB2442

Emergency Response and Overdose Prevention Act; amend to expand the distribution and use of opioid antagonists.

MI HB4366

Health: pharmaceuticals; distribution of naloxone under the administration of opioid antagonist act to any individual; provide for. Amends title & secs. 103 & 107 of 2019 PA 39 (MCL 15.673 & 15.677) & adds sec. 106. TIE BAR WITH: HB 4365'23